Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 24, 2020

Primary Completion Date

January 1, 2021

Study Completion Date

January 1, 2021

Conditions
Parkinson Disease
Interventions
OTHER

Therapeutic education workshop

"Workshop on Parkinson disease drug has several educative sequences (lasting 4hours).~* A first round table is organized to know the needs and issues related to drug management of patients.~* The 1st educative sequence consists in knowing the different class of dopaminergic drugs and their action.~* The 2nd educative sequence leads patients to understand their prescription and be aware of the needs to take pills regularly.~* The 3rd educative sequence consists in learning and identifying potentials adverse effects and finds effective strategies to prevent them.~At the end, one patient explains its tips and tricks about its drug management"

OTHER

Speaking Therapy

Speaking group is leaded by a psychologist from Centre Expert Parkinson (lasting 2 hours). This specific time is an exchange between patients with Parkinson disease who feel free to come. It is about sharing its own experience. It is a very special moment, confidential and kindly where patients don't judge themselves and speak only if they want to.

Trial Locations (1)

31059

Toulouse University Hospital, Toulouse

All Listed Sponsors
collaborator

France Parkinson Association

OTHER

lead

University Hospital, Toulouse

OTHER

NCT04228523 - Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED) | Biotech Hunter | Biotech Hunter